Breaking News Instant updates and real-time market news.

TITN

Titan Machinery

$23.62

0.56 (2.43%)

, SONC

Sonic

$27.26

-0.77 (-2.75%)

04:55
01/09/18
01/09
04:55
01/09/18
04:55

Stephens to hold meetings at conference

Stephens Company Meetings at ICR 2018 to be held in Orlando, FL on January 8-9.

TITN

Titan Machinery

$23.62

0.56 (2.43%)

SONC

Sonic

$27.26

-0.77 (-2.75%)

BGS

B&G Foods

$33.45

-1.15 (-3.32%)

UNFI

United Natural Foods

$47.12

2.24 (4.99%)

DENN

Denny's

$13.70

-0.1 (-0.72%)

CORE

Core-Mark

$25.68

1.5 (6.20%)

DFRG

Del Frisco's

$15.00

-0.15 (-0.99%)

YOGA

YogaWorks

$2.73

0.06 (2.25%)

RRGB

Red Robin

OLLI

Ollie's Bargain Outlet

$50.85

-2.65 (-4.95%)

TAST

Carrols Restaurant

$12.45

-0.25 (-1.97%)

  • 09

    Jan

  • 09

    Jan

  • 09

    Jan

  • 17

    Jan

TITN Titan Machinery
$23.62

0.56 (2.43%)

01/10/17
AGIS
01/10/17
INITIATION
Target $18
AGIS
Buy
Titan Machinery initiated with a Buy at Aegis
Aegis analyst Igor Maryasis initiated Titan Machinery with a Buy and a $18 price target saying shares currently trades below its tangible book value of just over $15 per share, to expects them to re-rate on delevered balance sheet and improved cost structure that position the company well for an eventual recovery in North American Ag equipment industry fundamentals.
12/01/17
BARD
12/01/17
NO CHANGE
Target $25
BARD
Outperform
Titan Machinery price target raised to $25 from $18 at Baird
Baird analyst Mig Dobre raised his price target on Titan Machinery to $25 from $18 following Q3 results. The analyst sees concrete signs of a turnaround in demand for agricultural equipment along with improving margins. He believes the recovery is in the early innings with demand bouncing off of multi-decade lows and looks at Titan as an under-the-radar play on that theme. Dobre reiterated his Outperform rating on Titan Machinery shares.
01/02/18
WBLR
01/02/18
UPGRADE
WBLR
Market Perform
Titan Machinery upgraded to Market Perform from Underperform at William Blair
William Blair analyst Larry De Maria upgraded Titan Machinery to Market Perform saying the worst is behind the company. The analyst expects "steady improvements" in 2018.
SONC Sonic
$27.26

-0.77 (-2.75%)

09/28/17
BARD
09/28/17
NO CHANGE
Target $20
BARD
Neutral
Sonic breach not material risk to processor First Data, says Baird
Baird analyst David Koning believes First Data (FDC) is the card processor for Sonic (SONC), which reported a security breach yesterday. The analyst believes it is possible the franchised locations of Sonic use different processors, so he does not view the breach as a material risk to First Data. Koning maintained his Neutral rating and $20 price target on First Data shares.
01/04/18
OPCO
01/04/18
DOWNGRADE
OPCO
Perform
Sonic downgraded to Perform from Outperform at Oppenheimer
Oppenheimer analyst Brian Bittner downgraded Sonic to Perform and removed his $29 price target on the shares. The analyst sees "limited catalysts from here" with the stock up 15% in a month. He sees above-average risk to the Street's same-store-sales and margins estimates in 2018.
01/04/18
OPCO
01/04/18
DOWNGRADE
OPCO
Perform
Sonic downgraded to Perform from Outperform at Oppenheimer
10/06/17
OPCO
10/06/17
NO CHANGE
Target $29
OPCO
Outperform
Sonic outlook to keep shares 'stalled' near term, says Oppenheimer
Oppenheimer analyst Brian Bittner expects Sonic's initial 2018 earnings outlook on October 16 to keep the shares "stalled" i in the near term. The analyst believes 2018 consensus estimates are "skewed a bit aggressively." His estimates are 5% below the Street. Bittner, however, see limited downside risk to Sonic shares without "significant" negative earnings revisions. He keeps an Outperform rating on the stock with a $29 price target.
BGS B&G Foods
$33.45

-1.15 (-3.32%)

11/01/17
SPHN
11/01/17
UPGRADE
Target $39
SPHN
Overweight
B&G Foods upgraded to Overweight from Equal Weight at Stephens
Stephens analyst Farha Aslam upgraded B&G Foods to Overweight from Equal Weight, citing the company's strong innovation, better execution and accretive acquisitions. The shares also have a "compelling" 5.7% dividend yield, added Aslam, who raised her price target on B&G to $39 from $35.
11/16/17
BREN
11/16/17
UPGRADE
BREN
Buy
B&G Foods upgraded to Buy from Hold at Berenberg
Bernenberg analyst Adam Mizrahl upgraded B&G Foods to Buy and raised its price target to $40 from $34 saying Green Giant potential is underestimated and tail brand declines are overestimates.
08/23/17
BUCK
08/23/17
UPGRADE
BUCK
Buy
B&G Foods upgraded to Buy from Neutral at Buckingham
08/23/17
BUCK
08/23/17
UPGRADE
BUCK
Buy
B&G Foods upgraded on improved outlook at Buckingham
As noted earlier, Buckingham upgraded B&G to Buy from Neutral. Analyst Eric Larson says that the company "is becoming more consolidated, with increasing exposure to advantaged categories." He thinks this trend will cause its profits to rise over the longer term, and he says that the company's comparisons are set to become more favorable. Target $40.
UNFI United Natural Foods
$47.12

2.24 (4.99%)

12/11/17
BMOC
12/11/17
NO CHANGE
Target $54
BMOC
Market Perform
United Natural Foods price target raised to $54 from $40 at BMO Capital
BMO Capital analyst Kelly Bahia raised her price target on United Natural Foods to $54 and kept her Market Perform rating following better than expected Q1 sales. Bahia says the quarter saw "acceleration across all channels" but that of the larger customers was particularly strong, adding that this mix-shift was behind the pressure on gross margins. The analyst expects United Natural Foods sales outlook to remain strong based on accelerating trends at Whole Foods.
11/14/17
GSCO
11/14/17
INITIATION
Target $41
GSCO
Neutral
United Natural Foods assumed with a Neutral at Goldman Sachs
Goldman analyst Christopher Prykull assumed coverage on United Natural Foods with a Neutral and $41 price target. Prykull said the shift towards mass is pressuring gross margins and will require ongoing opex efficiency to maintain margins.
12/08/17
LOOP
12/08/17
NO CHANGE
Target $56
LOOP
Buy
United Natural Foods price target raised to $56 from $50 at Loop Capital
Loop Capital analyst Andrew Wolf raised his price target on United Natural Foods to $56 after a "strong beat" on Q1 revenue. Wolf says the company's strategic changes have gained more traction, as international sales growth accelerated to 7.7% from 4.7% last quarter. The analyst keeps his Buy rating, stating that United Natural Foods remains attractively valued relative to historical averages while forecasting continued strong internally generated sales growth and modest operating leverage.
01/08/18
NRCS
01/08/18
UPGRADE
NRCS
Buy
United Natural Foods upgraded to Buy from Neutral at Northcoast
DENN Denny's
$13.70

-0.1 (-0.72%)

01/08/18
SPHN
01/08/18
NO CHANGE
SPHN
Denny's preannounces strong Q4 SSS, says Stephens
Stephens analyst Will Slabaugh noted that Denny's preliminary Q4 franchised SSS of +2.2% were ahead of Stephens estimates of +1.0% to +1.3%. Slabaugh believes the lower-end consumer will continue to strengthen due to benefits of tax reform and with Denny's positioning as a value leader in the full service space, he sees shares moving higher and remains a buyer of the stock. The analyst maintained an Overweight rating and $14 price target on Denny's shares.
CORE Core-Mark
$25.68

1.5 (6.20%)

01/05/18
RAJA
01/05/18
NO CHANGE
RAJA
Core-Mark shares defended at Raymond James
01/05/18
RAJA
01/05/18
UPGRADE
RAJA
Strong Buy
Core-Mark upgraded to Strong Buy from Outperform at Raymond James
01/05/18
01/05/18
UPGRADE

Core-Mark upgraded to Strong Buy, selloff overdone, says Raymond James
As previously reported, Raymond James upgraded Core-Mark to Strong Buy from Outperform with a $31 price target. Analyst Benjamin Brownlow said Core-Mark's preliminary 2017 results were disappointing but 2018 guidance looks conservative. Brownlow views the selloff in Core-Mark shares as overdone and a compelling buying opportunity particularly given easier year-over-year sales comps beginning in Q2 2018.
01/08/18
LOOP
01/08/18
NO CHANGE
Target $31
LOOP
Buy
Core-Mark price target lowered to $31 from $38 at Loop Capital
Loop Capital analyst Andrew Wolf lowered his price target on Core-Mark to $31 from $38 after the company cut its Q4 guidance on Friday in anticipation of the ICR Conference. Wolf says he now views Core-Mark management with "far greater circumspection", but remains confident that the company "remains very well positioned to profitably gain market share". Wolf keeps his Buy rating on Core-Mark, adding that its valuation is below the median of its peer Specialty Food Distributors group.
DFRG Del Frisco's
$15.00

-0.15 (-0.99%)

YOGA YogaWorks
$2.73

0.06 (2.25%)

11/03/17
11/03/17
INITIATION

On The Fly: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. YogaWorks (YOGA) initiated with an Outperform at Imperial Capital. 2. IRIDEX (IRIX) resumed with a Buy at Roth Capital. 3. TE Connectivity (TEL) initiated with an Outperform at Baird. 4. Pilgrim's Pride (PPC), Sanderson Farms (SAFM), and Tyson Foods (TSN) were initiated with an Equal Weight at Morgan Stanley, while Hormel Foods (HRL) initiated with an Underweight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
11/15/17
DADA
11/15/17
INITIATION
Target $3
DADA
Neutral
YogaWorks initiated with a Neutral at DA Davidson
DA Davidson started YogaWorks with a Neutral rating and $3 price target.
09/22/17
ROTH
09/22/17
NO CHANGE
Target $7
ROTH
Buy
YogaWorks shares remain undervalued, says Roth Capital
In a post-earnings research note, Roth Capital analyst Dave King said YogaWorks' results and guidance met expectations and he still sees a significant opportunity for the company to consolidate a highly-fragmented studio market. The analyst, who still views the shares as undervalued, keeps a Buy rating on YogaWorks.
11/03/17
IMPC
11/03/17
INITIATION
Target $5
IMPC
Outperform
YogaWorks initiated with an Outperform at Imperial Capital
Imperial Capital analyst George Kelly started YogaWorks with an Outperform rating and $5 price target. The analyst views the current risk/reward as compelling given the company's "strong" brand and "attractive" long-term model.
RRGB Red Robin

12/22/17
12/22/17
UPGRADE

On The Fly: Top analyst upgrades
Catch up on today's top analyst upgrades with this list compiled by The Fly: 1. Digital Realty (DLR) upgraded to Outperform from Market Perform at Wells Fargo with analyst Jennifer Fritzsche saying the 8% pullback in the shares since December 1 brings an attractive entry point considering improving fundamentals in fiscal 2018 and beyond. 2. Capital One (COF) upgraded to Buy from Neutral at Compass Point. 3. Red Robin (RRGB) was upgraded to Buy from Hold at Jefferies while Texas Roadhouse (TXRH) and Dunkin' Brands (DNKN) were upgraded to Hold from Underperform. 4. RE/MAX Holdings (RMAX) upgraded to Neutral from Sell at Compass Point. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/06/17
WELS
12/06/17
NO CHANGE
WELS
Tax reform-driven EPS accretion would be sizeable for restaurant sector, says Wells Fargo
Wells Fargo analyst Jeff Farmer says that small cap companies including Del Taco (TACO), Habit Restaurants (HABT), El Pollo Loco (LOCO), Shake Shack (SHAK) and Noodles & Company (NDLS) could see the largest EPS accretion tailwind from a reduced corporate tax rate, with Red Robin (RRGB), Restaurant Brands (QSR), Yum! Brands (YUM) and Bloomin' Brands (BLMN) the companies that could see the smallest tailwind. The analyst notes that recent restaurant sector rally indicates that virtually the entire sector has benefitted from anticipation of potential tax reform, with the most heavily shorted names seeing an amplified share price move.
12/22/17
JEFF
12/22/17
UPGRADE
Target $63
JEFF
Buy
Red Robin upgraded to Buy from Hold at Jefferies
Jefferies analyst Andy Barish upgraded Red Robin to Buy and raised his price target for the shares to $63 from $58. The analyst believes sentiment on the stock has turned too negative following the company's 2017 margin stumbles. He expects positive same-store-sales to return in 2018 and views the recent pullback in the shares as overdone.
01/02/18
WELS
01/02/18
NO CHANGE
WELS
Potbelly, Del Taco may see largest EPS tailwind from tax reform, says Wells Fargo
Wells Fargo argues that Potbelly (PBPB), Del Taco (TACO), El Pollo Loco (LOCO) and Jack in the Box (JACK) could see the largest EPS accretion tailwind from a reduced corporate tax rate, with Restaurant Brands (QSR), Red Robin (RRGB), Noodles & Company (NDLS) and Yum! Brands (YUM) the companies that could see the smallest tailwind. Recent restaurant rally indicates that virtually the entire sector has benefited from anticipation of potential tax reform, with the most heavily shorted names seeing an amplified move, the firm adds.
OLLI Ollie's Bargain Outlet
$50.85

-2.65 (-4.95%)

12/07/17
KEYB
12/07/17
NO CHANGE
Target $55
KEYB
Overweight
Ollie's Bargain Outlet price target raised to $55 from $50 at KeyBanc
KeyBanc analyst Bradley Thomas raised his price target for Ollie's Bargain Outlet to $55 from $50 following "strong" Q3 results. The analyst reiterates an Overweight rating on the shares.
12/07/17
PIPR
12/07/17
NO CHANGE
Target $61
PIPR
Overweight
Ollie's Bargain Outlet price target raised to $61 from $50 at Piper Jaffray
Piper Jaffray analyst Peter Keith raised his price target for Ollie's Bargain Outlet to $61 and reiterates an Overweight rating on the shares following the company's Q3 earnings. The analyst thinks Ollie's momentum will continue into Q4 and believes the company can sustain consistent comp growth of 2.0% in 2018-2019. He recommends using any modest pullbacks in the stock as buying opportunities.
12/05/17
JEFF
12/05/17
NO CHANGE
Target $57
JEFF
Buy
Ollie's Bargain Outlet price target raised to $57 from $50 at Jefferies
Jefferies analyst Daniel Binder raised his price target for Ollie's Bargain Outlet to $57 following field checks. A favorable buying environment and strong growth in Ollie's loyalty program should translate to good sales results in Q3, Binder tells investors in a research note. The analyst upped his Q3 comp store sales estimate to up 4% from up 2.5% and keeps a Buy rating on the shares.
11/17/17
11/17/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Boardwalk Pipeline (BWP) initiated with a Sell at Goldman Sachs. 2. Ollie's Bargain Outlet (OLLI) initiated with a Sell at Citi. 3. AMN Healthcare (AMN) initiated with an Overweight at KeyBanc. 4. Unilever (UL, UN) initiated with a Hold at Argus. 5. Canada Goose (GOOS) initiated with an Outperform at Cowen. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
TAST Carrols Restaurant
$12.45

-0.25 (-1.97%)

06/12/17
RAJA
06/12/17
NO CHANGE
Target $17
RAJA
Strong Buy
Carrols Restaurant recent weakness a buying opportunity, says Raymond James
Raymond James analyst Brian Vaccaro said near-term beef concerns has created an attractive entry point for Carrols Restaurant shares. The analyst said near-term comp acceleration will more than offset beef costs that he expects to moderate. With shares down approximately 10% in the past month, he would buy shares as he expects margin visibiliy to improve later in the year. Vaccaro rates Carrols a Strong Buy with a $17 price target.
09/26/17
09/26/17
DOWNGRADE
Target $15.5

Outperform
Carrols Restaurant downgraded to Outperform from Strong Buy at Raymond James
As previously reported, Raymond James downgraded Carrols Restaurant to Outperform from Strong Buy and maintained a $15.50 price target. Analyst Brian Vaccaro expects a higher level of discounting/promotions will pressure second half Burger King store margins, combined with high labor costs. As a result, the analyst lowered his 2017 EBITDA estimate to $87M, below guidance of $90M-$95M.
09/26/17
RAJA
09/26/17
DOWNGRADE
RAJA
Outperform
Carrols Restaurant downgraded to Outperform from Strong Buy at Raymond James

TODAY'S FREE FLY STORIES

BMY

Bristol-Myers

$62.28

0.45 (0.73%)

15:26
01/20/18
01/20
15:26
01/20/18
15:26
Hot Stocks
Opdivo, Yervoy combo demonstrates activity in patients with dMMR, MSI-H mCRC »

Bristol-Myers Squibb…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 05

    Feb

  • 08

    Feb

  • 05

    Mar

  • 08

    Mar

EXEL

Exelixis

$28.00

0.14 (0.50%)

, RHHBY

Roche

$30.69

0.18 (0.59%)

15:22
01/20/18
01/20
15:22
01/20/18
15:22
Hot Stocks
Exelixis presents updated results from Phase 1b clinical trial in CRC »

Exelixis (EXEL) announced…

EXEL

Exelixis

$28.00

0.14 (0.50%)

RHHBY

Roche

$30.69

0.18 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 01

    Feb

  • 08

    Feb

  • 15

    Feb

  • 23

    Feb

ARRY

Array BioPharma

$13.14

0.26 (2.02%)

15:17
01/20/18
01/20
15:17
01/20/18
15:17
Hot Stocks
Array BioPharma updates results from BEACON Phase 3 trial »

Array BioPharma and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jun

  • 30

    Jun

SO

Southern Company

$44.44

-0.46 (-1.02%)

15:13
01/20/18
01/20
15:13
01/20/18
15:13
Hot Stocks
Southern Company accelerates restoration efforts in Puerto Rico »

Southern Company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TECK

Teck Resources

$29.43

0.19 (0.65%)

15:10
01/20/18
01/20
15:10
01/20/18
15:10
Hot Stocks
Teck Resources announces Elkview incident »

Teck Resources announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

TWTR

Twitter

$23.66

-0.38 (-1.58%)

14:03
01/20/18
01/20
14:03
01/20/18
14:03
Hot Stocks
Twitter begins notifying users exposed to Russian propaganda during elections »

Twitter, which is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

SPY

SPDR S&P 500 ETF Trust

$280.41

1.27 (0.45%)

, SPX

S&P 500

13:58
01/20/18
01/20
13:58
01/20/18
13:58
Periodicals
Government shuts down on anniversary of Trump presidency, Reuters reports »

President's Trump…

SPY

SPDR S&P 500 ETF Trust

$280.41

1.27 (0.45%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$181.29

1.49 (0.83%)

, NYT

New York Times

$21.90

1.7 (8.42%)

13:48
01/20/18
01/20
13:48
01/20/18
13:48
Periodicals
NY Times stock jumps after Facebook's announcement, Recode reports »

Facebook (FB) CEO Mark…

FB

Facebook

$181.29

1.49 (0.83%)

NYT

New York Times

$21.90

1.7 (8.42%)

NWSA

News Corp.

$17.22

0.21 (1.23%)

FOXA

21st Century Fox

$36.65

0.47 (1.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 31

    Jan

  • 07

    Feb

  • 07

    Feb

  • 28

    Feb

WMT

Walmart

$104.59

0.29 (0.28%)

13:36
01/20/18
01/20
13:36
01/20/18
13:36
Periodicals
Still time to shop Walmart shares as company makes changes, Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

AAPL

Apple

$178.46

-0.8 (-0.45%)

, NFLX

Netflix

$220.46

0.13 (0.06%)

08:59
01/20/18
01/20
08:59
01/20/18
08:59
Periodicals
Netflix among likely candidates for an Apple purchase, Barron's says »

Especially for tech…

AAPL

Apple

$178.46

-0.8 (-0.45%)

NFLX

Netflix

$220.46

0.13 (0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 30

    Jan

  • 01

    Feb

BA

Boeing

$337.73

-2.43 (-0.71%)

08:50
01/20/18
01/20
08:50
01/20/18
08:50
Periodicals
Boeing not a sell just yet, Barron's says »

Boeing stock has come…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

  • 21

    Feb

AAPL

Apple

$178.46

-0.8 (-0.45%)

, EADSY

Airbus

$28.43

0.755 (2.73%)

08:24
01/20/18
01/20
08:24
01/20/18
08:24
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AAPL

Apple

$178.46

-0.8 (-0.45%)

EADSY

Airbus

$28.43

0.755 (2.73%)

BA

Boeing

$337.73

-2.43 (-0.71%)

VZ

Verizon

$51.91

0.36 (0.70%)

NYT

New York Times

$21.90

1.7 (8.42%)

TWX

Time Warner

$93.36

0.39 (0.42%)

DIS

Disney

$110.59

0.17 (0.15%)

TIME

Time Inc.

$18.55

0.05 (0.27%)

AMZN

Amazon.com

$1,294.58

1.26 (0.10%)

BAC

Bank of America

$31.72

0.24 (0.76%)

GS

Goldman Sachs

$256.12

5.15 (2.05%)

BK

BNY Mellon

$56.61

1.26 (2.28%)

WLKP

Westlake Chemical Partners

$24.45

-0.1 (-0.41%)

MON

Monsanto

$120.66

1.8 (1.51%)

DLTR

Dollar Tree

$114.73

1.83 (1.62%)

CE

Celanese

$112.96

1.93 (1.74%)

LYB

LyondellBasell

$119.92

3.03 (2.59%)

TSE

Trinseo

$79.45

2.2 (2.85%)

EYE

National Vision

$43.13

1.12 (2.67%)

ETFC

E-Trade

$54.28

0.63 (1.17%)

LPLA

LPL Financial

$59.03

0.53 (0.91%)

AMTD

TD Ameritrade

$55.17

0.21 (0.38%)

SCHW

Charles Schwab

$55.48

0.15 (0.27%)

ADS

Alliance Data

$261.82

5.88 (2.30%)

FISV

Fiserv

$138.11

0.17 (0.12%)

FLT

FleetCor

$206.65

3.4 (1.67%)

HAWK

Blackhawk

$45.25

0.1 (0.22%)

MTZ

MasTec

$53.30

1.25 (2.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 25

    Jan

  • 25

    Jan

  • 26

    Jan

  • 31

    Jan

  • 31

    Jan

  • 31

    Jan

  • 01

    Feb

  • 01

    Feb

  • 01

    Feb

  • 02

    Feb

  • 06

    Feb

  • 07

    Feb

  • 15

    Feb

  • 16

    Feb

  • 21

    Feb

  • 08

    Mar

  • 18

    Mar

CME

CME Group

$154.28

2.07 (1.36%)

, GS

Goldman Sachs

$256.12

5.15 (2.05%)

04:55
01/20/18
01/20
04:55
01/20/18
04:55
Conference/Events
American Bar Association to hold annual meeting »

Derivatives & Futures…

CME

CME Group

$154.28

2.07 (1.36%)

GS

Goldman Sachs

$256.12

5.15 (2.05%)

BP

BP

$42.40

-0.5 (-1.17%)

C

Citi

$78.30

0.91 (1.18%)

BAC

Bank of America

$31.72

0.24 (0.76%)

CS

Credit Suisse

$19.06

0.13 (0.69%)

CRL

Charles River

$107.89

1.22 (1.14%)

MS

Morgan Stanley

$57.46

1.62 (2.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jan

  • 24

    Jan

  • 31

    Jan

  • 01

    Feb

  • 15

    Feb

AMGN

Amgen

$189.28

1.69 (0.90%)

, BAYRY

Bayer

$32.05

0.235 (0.74%)

04:55
01/20/18
01/20
04:55
01/20/18
04:55
Conference/Events
American Society of Clinical Oncology to hold a symposium »

2018 ASCO…

AMGN

Amgen

$189.28

1.69 (0.90%)

BAYRY

Bayer

$32.05

0.235 (0.74%)

BLRX

BioLineRx

$1.09

-0.02 (-1.80%)

BMY

Bristol-Myers

$62.28

0.45 (0.73%)

CELG

Celgene

$102.65

0.93 (0.91%)

DNA

Bought by RHHBY

ESALY

Eisai

$56.88

0.115 (0.20%)

EXEL

Exelixis

$28.00

0.14 (0.50%)

HALO

Halozyme

$17.98

0.13 (0.73%)

INCY

Incyte

$93.16

1.24 (1.35%)

IPSEY

Ipsen

$34.65

0.75 (2.21%)

LXRX

Lexicon

$10.44

0.2 (1.95%)

MGNX

MacroGenics

$19.19

0.3 (1.59%)

MRK

Merck

$61.28

0.15 (0.25%)

NVS

Novartis

$86.94

0.53 (0.61%)

SNY

Sanofi

$44.60

0.09 (0.20%)

ONCY

Oncolytics

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

  • 25

    Jan

  • 02

    Feb

  • 03

    Feb

  • 05

    Feb

  • 08

    Feb

  • 15

    Feb

  • 16

    Feb

  • 02

    Mar

  • 05

    Mar

  • 08

    Mar

  • 25

    Mar

  • 03

    Apr

  • 23

    Apr

  • 30

    Apr

  • 02

    May

  • 17

    May

  • 28

    May

  • 23

    Oct

WLFC

Willis Lease

$26.66

0.05 (0.19%)

18:59
01/19/18
01/19
18:59
01/19/18
18:59
Hot Stocks
Willis Lease announces $1,000 bonus for employees »

Willis Lease announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DPS

Dr Pepper Snapple

$96.35

1.03 (1.08%)

18:13
01/19/18
01/19
18:13
01/19/18
18:13
Hot Stocks
Dr Pepper to become official sponsor of esports team TSM »

Dr Pepper announced it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RCII

Rent-A-Center

$11.70

0.09 (0.78%)

17:53
01/19/18
01/19
17:53
01/19/18
17:53
Hot Stocks
Vintage Capital in standstill pact with Rent-A-Center »

On January 17, Vintage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AR

Antero Resources

$18.74

-0.59 (-3.05%)

17:44
01/19/18
01/19
17:44
01/19/18
17:44
Recommendations
Antero Resources analyst commentary at MUFG »

Antero Resources price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$37.21

0.06 (0.16%)

, TWX

Time Warner

$93.36

0.39 (0.42%)

17:44
01/19/18
01/19
17:44
01/19/18
17:44
Periodicals
AT&T requesting docs from companies in Time Warner deal hearing, Reuters says »

AT&T (T) is…

T

AT&T

$37.21

0.06 (0.16%)

TWX

Time Warner

$93.36

0.39 (0.42%)

VZ

Verizon

$51.91

0.36 (0.70%)

CMCSA

Comcast

$42.50

0.65 (1.55%)

CMCSK

Comcast

DISH

Dish

$45.26

0.1 (0.22%)

CHTR

Charter

$366.05

0.8 (0.22%)

DIS

Disney

$110.59

0.17 (0.15%)

VIA

Viacom

$39.20

-0.5 (-1.26%)

VIAB

Viacom

$33.36

-0.59 (-1.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

  • 24

    Jan

  • 31

    Jan

  • 02

    Feb

  • 06

    Feb

  • 08

    Feb

  • 08

    Feb

GRPN

Groupon

$5.57

0.46 (9.00%)

17:44
01/19/18
01/19
17:44
01/19/18
17:44
Hot Stocks
Groupon announces Chief Product Officer Jay Sullivan resigns »

On January 17, Jay…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CELG

Celgene

$102.65

0.93 (0.91%)

17:41
01/19/18
01/19
17:41
01/19/18
17:41
Hot Stocks
Celgene's Abraxane exceeds primary endpoint target in pancreatic cancer trial »

Celgene announced primary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

VALU

Value Line

$19.60

0.3 (1.55%)

17:40
01/19/18
01/19
17:40
01/19/18
17:40
Hot Stocks
Value Line reaffirms $3M stock repurchase program »

The Board of Directors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VALU

Value Line

$19.60

0.3 (1.55%)

17:39
01/19/18
01/19
17:39
01/19/18
17:39
Hot Stocks
Value Line declares special dividend of 20c per share »

Payable on March 9 to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZEAL

Zealand Pharma

$15.05

-0.78 (-4.93%)

17:34
01/19/18
01/19
17:34
01/19/18
17:34
Hot Stocks
Zealand Pharma: FDA approves IND for Phase 3 trials of dasiglucagon in CHI »

The U.S. FDA has approved…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GNMSF

Genmab

$190.75

2.75 (1.46%)

, JNJ

Johnson & Johnson

$147.36

0.44 (0.30%)

17:29
01/19/18
01/19
17:29
01/19/18
17:29
Hot Stocks
Genmab says FDA grants priority review for daratumumab »

Genmab (GNMSF) announced…

GNMSF

Genmab

$190.75

2.75 (1.46%)

JNJ

Johnson & Johnson

$147.36

0.44 (0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 23

    Jan

  • 16

    Feb

  • 08

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.